<DOC>
	<DOCNO>NCT01414309</DOCNO>
	<brief_summary>Central sleep apnea ( CSA ) associate increased mortality primarily occur patient heart failure ( HF ) . The primary purpose study document natural progression moderate severe CSA heart failure patient .</brief_summary>
	<brief_title>Prospective Evaluation Heart Failure Patients With Central Sleep Apnea</brief_title>
	<detailed_description>This trial prospective , non-randomized observational study heart failure patient moderate severe central sleep apnea ( CSA ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Central</mesh_term>
	<criteria>Subject willing able comply protocol sign IRB/MEC approve informed consent ( well Privacy Protection Authorization United States ) Age great equal 18 year Known recent history sleep disorder breathe predominantly central origin , evidence overnight PSG EEG least 4 hour record conduct within 60 day enrollment demonstrate follow characteristic : AHI great equal 20 great equal 50 % classified event central nature le 20 % total AHI comprise obstructive apnea event Diagnosed chronic heart failure , medication optimize stable least 30 day prior screen PSG , since date early test use baseline , whichever longer . Optimal medication include : beta blockade , ACEI ARB diuretic unless contraindicate consider medically necessary . Current intend use maskbased therapy central sleep apnea Baseline oxygen saturation less equal 90 % stable FiO2 Severe Chronic Obstructive Pulmonary Disease ( COPD ) ( per GOLD classification system ) History cerebrovascular accident ( CVA ) , myocardial infarction ( MI ) , coronary artery bypass grafting ( CABG ) surgery , percutaneous coronary intervention ( PCI ) , cardiac ablation procedure within 3 month prior study Unstable angina History primary pulmonary hypertension Currently enrol nonobservational ( ie , interventional ) clinical study could confound result study If subject implant cardiac resynchronization device ( CRT ) , must implant least 3 month enrollment ; device must implant least 30 day prior enrollment Life expectancy le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Central Sleep Apnea</keyword>
	<keyword>Sleep Disordered Breathing</keyword>
	<keyword>Cardiac Dysfunction</keyword>
</DOC>